(Q35737321)

10 August 2017

Neuropsychological impairment in borderline personality disorder (English)

1 reference

borderline personality disorder

10 August 2017

0 references

1 reference

2

1 reference

10 August 2017

Elena S Monarch

1

1 reference

PubMed ID

15062631

10 August 2017

Laura A Flashman

series ordinal

3

1 reference

10 August 2017

1 March 2004

1 reference

Psychiatric Clinics of North America

10 August 2017

1 reference

10 August 2017

27

1 reference

10 August 2017

1

1 reference

10 August 2017

67-82, viii-ix

1 reference

Prognostic Considerations Regarding Borderline Personality Organization

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Neuropsychological testing of patients with borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Neurocognitive deficits in decision-making and planning of patients with DSM-III-R borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Neuropsychological functioning in patients with borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Case series: PTSD symptoms in adolescent survivors of "ethnic cleansing." Results from a 1-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Diatheses and stressors in borderline pathology of childhood: the role of neuropsychological risk and trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Relationship of depression and cognitive impairment to self-injury in borderline personality disorder, major depression, and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Organic Brain Dysfunction and the Borderline Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Soft sign neurological abnormalities in borderline personality disorder and normal control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Neuropsychiatric impairment in impulsive personality disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Electroencephalography of DSM-III borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Symptoms and EEG findings in the borderline syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Auditory P300 in borderline personality disorder and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Ventricular enlargement in teenage patients with schizophrenia spectrum disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Cerebral structure in borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Positron-emission tomography and personality disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Positron emission tomography in female patients with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Brain Regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Neuropsychological function in borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Neurocognitive impairment in dramatic personalities: histrionic, narcissistic, borderline, and antisocial disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Normative neuropsychological test performance: effects of age, education, gender and ethnicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

The measurement of differential deficit

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Cognitive-Behavioral Treatment of Chronically Parasuicidal Borderline Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900109-6

7 January 2021

10.1016/S0193-953X(03)00109-6

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15062631